Artiva Biotherapeutics (ARTV) Change in Account Payables (2023 - 2026)
Artiva Biotherapeutics' (ARTV) quarterly Change in Account Payables came in at $1.8 million in Q1 2026, up 4319.51% year-on-year from $41000.0 in Q1 2025, and up 1308.0% on a QoQ basis from -$150000.0 in Q4 2025.
Artiva Biotherapeutics (ARTV) Change in Account Payables (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has 4 years of Change in Account Payables data on file, last reported at $1.8 million in Q1 2026.
- On a quarterly basis, Change in Account Payables rose 4319.51% year-over-year to $1.8 million in Q1 2026; TTM through Mar 2026 was $1.0 million, a 447.42% increase from a year earlier, with the FY2025 full-year figure at -$760000.0, down 246.44% from the prior year.
- Change in Account Payables for Q1 2026 stood at $1.8 million, up from -$150000.0 in the prior quarter.
- Over the last five years, Change in Account Payables for ARTV reached as high as $1.8 million in Q1 2026 and fell as low as -$1.9 million in Q4 2023.
- Historically, Change in Account Payables has averaged $112272.7 across 4 years, with a median of -$82000.0 in 2024.
- Across the five-year window, Change in Account Payables plunged 162.78% in 2025 and jumped 4319.51% in 2026, its largest moves.
- Year by year, Change in Account Payables stood at -$1.9 million in 2023, then jumped by 95.73% to -$82000.0 in 2024, then plunged by 82.93% to -$150000.0 in 2025, then jumped by 1308.0% to $1.8 million in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were $1.8 million in Q1 2026, -$150000.0 in Q4 2025, and -$442000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Artiva Biotherapeutics | 249.99 Mn | 249.99 Mn | - | 1.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.81 Mn |
| Mar 31, 2026 | 1.81 Mn |
| Dec 31, 2025 | -150,000.00 |
| Dec 31, 2025 | -150,000.00 |
| Sep 30, 2025 | -442,000.00 |
| Sep 30, 2025 | -442,000.00 |
| Jun 30, 2025 | -209,000.00 |
| Jun 30, 2025 | -209,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Dec 31, 2024 | -82,000.00 |
| Dec 31, 2024 | -82,000.00 |
| Sep 30, 2024 | 704,000.00 |
| Sep 30, 2024 | 704,000.00 |
| Jun 30, 2024 | -954,000.00 |
| Jun 30, 2024 | -954,000.00 |
| Mar 31, 2024 | 851,000.00 |
| Mar 31, 2024 | 851,000.00 |
| Dec 31, 2023 | -1.92 Mn |
| Dec 31, 2023 | -1.92 Mn |